Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Nusantara Inti Corpora Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Nusantara Inti Corpora Tbk diperdagangkan di Rp316 (kapitalisasi pasar 23,83 M). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. jauh lebih besar — sekitar 7× kapitalisasi pasar Nusantara Inti Corpora Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | UNIT | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 23,83 M |
Volume | 324 rb | — |
Lot | 3,24 rb | — |
Perputaran | 77,68 jt | — |
Harga Rata-rata | 239,75 | — |
Nilai Transaksi | 77,68 jt | — |
Harga Ekuilibrium Indikatif | 240 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Established in Jakarta on 1988 named PT. Aneka Keloladana. On July 2001 changed the name to PT. United Capital Indonesia. Beside as broker dealer in Capital Market, the corporate also provide the services such as financial advisory, research. Average employees are 28 staffs.On July 06 2007, PT United Capital Indonesia Tbk has changed its name as PT Nusantara Inti Corpora Tbk.
Selengkapnya di halaman UNIT →